These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 191534

  • 41. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
    Kedar E, Bonavida B.
    J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
    [No Abstract] [Full Text] [Related]

  • 42. [The current state of the search for tumor-specific transplantation antigens in human leukemias].
    Zintl F, Plenert W.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971 Oct; 95(1):1-20. PubMed ID: 4104078
    [No Abstract] [Full Text] [Related]

  • 43. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH, Armstrong MY, Richards FF.
    J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.
    Zinkernagel RM, Welsh RM.
    J Immunol; 1976 Nov; 117(5 Pt 1):1495-502. PubMed ID: 794412
    [Abstract] [Full Text] [Related]

  • 46. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW, Demsey A.
    Invasion Metastasis; 1984 Nov; 4(1):28-46. PubMed ID: 6329988
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Studies of the mechanisms for the induction of in vivo tumor immunity. III. Recruitment of host helper cells by donor T cells in adoptive transfer of cell-mediated immunity.
    Ting CC, Rodrigues D, Igarashi T.
    J Immunol; 1979 Apr; 122(4):1510-8. PubMed ID: 221575
    [No Abstract] [Full Text] [Related]

  • 50. The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.
    Fujiwara H, Hamaoka T, Shearer GM, Yamamoto H, Terry WD.
    J Immunol; 1980 Feb; 124(2):863-9. PubMed ID: 6965392
    [No Abstract] [Full Text] [Related]

  • 51. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N, Fontaine P, Perreault C.
    Transplantation; 1994 Jul 15; 58(1):59-67. PubMed ID: 8036709
    [Abstract] [Full Text] [Related]

  • 52. Allogeneic mouse T cell lines distinguish three Balb/c leukemias from each other and from non-leukemic lymphocytes.
    Sebens T, Uharek L, Glass B, Müller-Ruchholtz W, Steinmann J.
    Bone Marrow Transplant; 1995 Sep 15; 16(3):443-9. PubMed ID: 8535318
    [Abstract] [Full Text] [Related]

  • 53. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC, Prager MD.
    Cancer Res; 1977 Feb 15; 37(2):507-13. PubMed ID: 832275
    [Abstract] [Full Text] [Related]

  • 54. Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells.
    Berenson JR, Einstein AB, Fefer A.
    J Immunol; 1975 Jul 15; 115(1):234-8. PubMed ID: 1080165
    [Abstract] [Full Text] [Related]

  • 55. Lectin-dependent cell-mediated cytotoxicity: assessment of cytotoxic reactivity following challenge with syngeneic tumors.
    Laux DC, Parker BM, DiSciullo SO, Petrarca MA, McAllister CG.
    J Natl Cancer Inst; 1984 Mar 15; 72(3):667-72. PubMed ID: 6583449
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.
    Gooding LR.
    J Immunol; 1977 Mar 15; 118(3):920-7. PubMed ID: 191529
    [Abstract] [Full Text] [Related]

  • 60. Studies on the specificity of in vitro induced lymphocytotoxicity to SV40-transformed fibroblasts.
    Warnatz H, Krapf F.
    J Immunol; 1976 Sep 15; 117(3):981-5. PubMed ID: 182884
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.